Details for New Drug Application (NDA): 205885
✉ Email this page to a colleague
The generic ingredient in TADALAFIL is tadalafil. There are twenty-five drug master file entries for this compound. Forty-eight suppliers are listed for this compound. Additional details are available on the tadalafil profile page.
Summary for 205885
Tradename: | TADALAFIL |
Applicant: | Watson Labs Inc |
Ingredient: | tadalafil |
Patents: | 0 |
Pharmacology for NDA: 205885
Mechanism of Action | Phosphodiesterase 5 Inhibitors |
Medical Subject Heading (MeSH) Categories for 205885
Suppliers and Packaging for NDA: 205885
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
TADALAFIL | tadalafil | TABLET;ORAL | 205885 | ANDA | Teva Pharmaceuticals, Inc. | 0480-2309 | 0480-2309-56 | 30 TABLET, FILM COATED in 1 BOTTLE (0480-2309-56) |
TADALAFIL | tadalafil | TABLET;ORAL | 205885 | ANDA | Teva Pharmaceuticals, Inc. | 0480-2310 | 0480-2310-56 | 30 TABLET, FILM COATED in 1 BOTTLE (0480-2310-56) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 2.5MG | ||||
Approval Date: | Mar 29, 2019 | TE: | AB1 | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
Approval Date: | Mar 29, 2019 | TE: | AB1 | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 10MG | ||||
Approval Date: | Mar 29, 2019 | TE: | AB1 | RLD: | No |
Complete Access Available with Subscription